C07K 16/2872
Against prion molecules
Official title: {against prion molecules, e.g. CD230}
C07K16/2872 (Against prion molecules) appears on 37 US grants and 62 published applications in this corpus.
Search patents in C07K- Granted patents
- 37
- Published applications
- 62
- Assignees
- 46
- Inventors
- 114
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 2 |
| 2002 | 0 | 1 |
| 2003 | 3 | 3 |
| 2004 | 1 | 2 |
| 2005 | 1 | 0 |
| 2006 | 2 | 4 |
| 2007 | 2 | 3 |
| 2008 | 1 | 5 |
| 2009 | 0 | 3 |
| 2010 | 0 | 3 |
| 2011 | 2 | 4 |
| 2012 | 1 | 2 |
| 2013 | 0 | 1 |
| 2014 | 2 | 4 |
| 2015 | 2 | 2 |
| 2016 | 3 | 4 |
| 2017 | 0 | 5 |
| 2018 | 2 | 0 |
| 2019 | 4 | 4 |
| 2020 | 2 | 1 |
| 2021 | 1 | 3 |
| 2022 | 0 | 3 |
| 2023 | 1 | 1 |
| 2024 | 2 | 1 |
| 2025 | 0 | 0 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Binding molecule binding to traumatic brain injury-associated tau and methods of use thereof23 Jun 2026US 12,662,678 B2Arizona Board of Regents on behalf of Arizona State University
- Vaccine comprising protein-targeted (PT) extracellular DNA isolated from bacterial matrix27 Jan 2026US 12,535,491 B2
- Method for treating a neurodegenerative disease by administering an anti-cellular prion protein (PrPc) antibody8 Oct 2024US 12,110,336 B2MedImmune, LLC
- Innocuous, structured scaffolds for structure-based amyloid disease vaccines and antigens24 Sep 2024US 12,098,173 B2The Governors of the University of Alberta
- Human alzheimer's disease and traumatic brain injury associated tau variants as biomarkers and methods of use thereof10 Jan 2023US 11,549,113 B2Arizona Board of Regents on behalf of Arizona State University
- Tetz-proteins and prion-like proteins and associated methods6 Aug 2026US 2026/0227416 A1
- Anti-doppel antibody drug conjugates21 Mar 2024US 2024/0091372 A1Osong Medical Innovation Foundation
- Human alzheimer's disease and traumatic brain injury associated tau variants as biomarkers and methods of use thereof13 Jul 2023US 2023/0220401 A1Arizona Board of Regents on behalf of Arizona State University
- Pharmaceutical composition comprising prion protein-specific antibody1 Dec 2022US 2022/0380477 A1Stem Bio Co., Ltd.
- Compositions and methods for the treatment and prevention of prion disease6 Oct 2022US 2022/0313802 A1Instituto Nacional de Tecnologia Agropecuaria (INTA)
Most cited
By later US patents
- Assay for disease related conformation of a protein29US 5,891,641 AThe Regents of the University of California · 1999
- Immunological detection of prions25US 6,765,088 B1UniversitäT ZüRich · 2004
- Removal of prions from blood, plasma and other liquids24US 6,221,614 B1The Regents of the University of California · 2001
- Biological materials and methods useful in the diagnosis and treatment of diseases10US 6,534,036 B1D-Gen Limited · 2003
- Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies9US 6,261,790 B1The United States of America as represented by the Secretary of Agriculture · 2001